Effect of age on sexually dimorphic selenoprotein expression in mice

Biological Chemistry

Volumn 388, Issue 10, 2007, Pages 1035-1041

  Schomburg, Lutz ^a   Riese, Cornelia ^a   Renko, Kostja ^a   Schweizer, Ulrich ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Deiodinase; Gender; Stability; Trace element; Translational efficiency

Indexed keywords

DEIODINASE I; GLUTATHIONE PEROXIDASE; KIDNEY ENZYME; LIVER ENZYME; MESSENGER RNA; SELENIUM; SELENOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; REGULATORY MECHANISM; SEX DIFFERENCE; TISSUE SPECIFICITY;

AGE FACTORS; ANIMALS; FEMALE; GENE EXPRESSION REGULATION; IODIDE PEROXIDASE; KIDNEY; LIVER; MALE; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; RNA, MESSENGER; SELENOPROTEINS; SEX CHARACTERISTICS;

MUS;

EID: 35348905550     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2007.128     Document Type: Article

References (49)

1. Al-Taie, O.H., Seufert, J., Mörk, H., Treis, H., Mentrup, B., Thalheimer, A., Starostik, P., Abel, J., Scheurlen, M., Köhrle, J., and Jakob, F. (2002). A complex DNA-repeat structure within the Selenoprotein P promoter contains a functionally relevant polymorphism and is genetically unstable under conditions of mismatch repair deficiency. Eur. J. Hum. Genet. 10, 499-504.
2. Angstwurm, M.W., Engelmann, L., Zimmermann, T., Lehmann, C., Spes, C.H., Abel, P., Strauss, R., Meier-Hellmann, A., Insel, R., Radke, J., et al. (2007). Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit. Care Med. 35, 118-126.
3. Beckett, G.J. and Arthur, J.R. (2005). Selenium and endocrine systems. J. Endocrinol. 184, 455-465.
4. Behne, D., Hilmert, H., Scheid, S., Gessner, H., and Elger, W. (1988). Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochim. Biophys. Acta 966, 12-21.
5. Birringer, M., Pilawa, S., and Flohé, L. (2002). Trends in selenium biochemistry. Nat. Prod. Rep. 19, 693-718.
6. Bjelakovic, G., Nikolova, D., Gluud, L.L., Simonetti, R.G., and Gluud, C. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. J. Am. Med. Assoc. 297, 842-857.
7. Blankenberg, S., Rupprecht, H.J., Bickel, C., Torzewski, M., Hafner, G., Tiret, L., Smieja, M., Cambien, F., Meyer, J., and Lackner, K.J. (2003). Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N. Engl. J. Med. 349, 1605-1613.
8. Bräuer, V.F., Schweizer, U., Köhrle, J., and Paschke, R. (2006). Selenium and goiter prevalence in borderline iodine sufficiency. Eur. J. Endocrinol. 155, 807-812.
9. Burk, R.F. and Hill, K.E. (2005). Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu. Rev. Nutr. 25, 215-235.
10. Clark, L.C., Combs, G.F. Jr., Turnbull, B.W., Slate, E.H., Chalker, D.K., Chow, J., Davis, L.S., Glover, R.A., Graham, G.F., Gross, E.G., et al. (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. J. Am. Med. Assoc. 276, 1957-1963.
11. Combs, G.F. Jr. (2004). Status of selenium in prostate cancer prevention. Br. J. Cancer 91, 195-199.
12. Combs, G.F. Jr. and Combs, S.B. (1984). The nutritional biochemistry of selenium. Annu. Rev. Nutr. 4, 257-280.
13. Derumeaux, H., Valeix, P., Castetbon, K., Bensimon, M., Boutron-Ruault, M.C., Arnaud, J., and Hercberg, S. (2003). Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. Eur. J. Endocrinol. 148, 309-315.
14. Diamond, A.M., Jaffe, D., Murray, J.L., Safa, A.R., Samuels, B.L., and Hatfield, D.L. (1996). Lovastatin effects on human breast carcinoma cells. Differential toxicity of an adriamycin-resistant derivative and influence on selenocysteine tRNAs. Biochem. Mol. Biol. Int. 38, 345-355.
15. Drasch, G., Mail der, S., Schlosser, C., and Roider, G. (2000). Content of non-mercury-associated selenium in human tissues. Biol. Trace Elem. Res. 77, 219-230.
16. Driscoll, D.M. and Copeland, P.R. (2003). Mechanism and regulation of selenoprotein synthesis. Annu. Rev. Nutr. 23, 17-40.
17. Ducros, V., Ferry, M., Faure, P., Belin, N., Renversez, J.C., Ruffieux, D., and Favier, A. (2000). Distribution of selenium in plasma of French women: relation to age and selenium status. Clin. Chem. 46, 731-733.
18. Dumitrescu, A.M., Liao, X.H., Abdullah, M.S., Lado-Abeal, J., Majed, F.A., Moeller, L.C., Boran, G., Schomburg, L., Weiss, R.E., and Refetoff, S. (2005). Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat. Genet. 37, 1247-1252.
19. Duntas, L.H. (2006). The role of selenium in thyroid autoimmunity and cancer. Thyroid 16, 455-460.
20. Forceville, X., Vitoux, D., Gauzit, R., Combes, A., Lahilaire, P., and Chappuis, P. (1998). Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit. Care Med. 26, 1536-1544.
21. Galan, P., Viteri, F.E., Bertrais, S., Czernichow, S., Faure, H., Arnaud, J., Ruffieux, D., Chenal, S., Arnault, N., Favier, A., et al. (2005). Serum concentrations of β-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. Eur. J. Clin. Nutr. 59, 1181-1190.
22. Gärtner, R., Gasnier, B.C., Dietrich, J.W., Krebs, B., and Angstwurm, M.W. (2002). Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J. Clin. Endocrinol. Metab. 87, 1687-1691.
23. Gromer, S., Eubel, J.K., Lee, B.L., and Jacob, J. (2005). Human selenoproteins at a glance. Cell. Mol. Life Sci. 62, 2414-2437.
24. Handy, D.E., Hang, G., Scolaro, J., Metes, N., Razaq, N., Yang, Y., and Loscalzo, J. (2006). Aminoglycosides decrease glutathione peroxidase-1 activity by interfering with selenocysteine incorporation. J. Biol. Chem. 281, 3382-3388.
25. Hill, K.E., Zhou, J., McMahan, W.J., Motley, A.K., Atkins, J.F., Gesteland, R.F., and Burk, R.F. (2003). Deletion of selenoprotein P alters distribution of selenium in the mouse. J. Biol. Chem. 278, 13640-13646.
26. Klein, E.A., Thompson, I.M., Lippman, S.M., Goodman, P.J., Albanes, D., Taylor, P.R., and Coltman, C. (2001). SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial. J. Urol. 166, 1311-1315.
27. Köhrle, J., Brigelius-Flohé, R., Böck, A., Gärtner, R., Meyer, O., and Flohé, L. (2000). Selenium in biology: facts and medical perspectives. Biol. Chem. 381, 849-864.
28. Köhrle, J., Jakob, F., Contempre, B., and Dumont, J.E. (2005). Selenium, the thyroid, and the endocrine system. Endocr. Rev. 26, 944-984.
29. Nawrot, T.S., Staessen, J.A., Roels, H.A., Den Hond, E., Thijs, L., Fagard, R.H., Dominiczak, A.F., and Struijker-Boudier, H.A. (2007). Blood pressure and blood selenium: a cross-sectional and longitudinal population study. Eur. Heart J. 28, 628-633.
30. Pattyn, F., Robbrecht, P., De Paepe, A., Speleman, F., and Vandesompele, J. (2006). RTPrimerDB: the real-time PCR primer and probe database, major update 2006. Nucleic Acids Res. 34, D684-688 (database issue).
31. Pfaffl, M.W., Horgan, G.W., and Dempfle, L. (2002). Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36.
32. Rayman, M.P. (2002). The argument for increasing selenium intake. Proc. Nutr. Soc. 61, 203-215.
33. Riese, C., Michaelis, M., Mentrup, B., Götz, F., Köhrle, J., Schweizer, U., and Schomburg, L. (2006). Selenium-dependent pre- and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues. Endocrinology 147, 5883-5892.
34. Sattar, N., Eatock, F., Fell, G.S., and O'Reilly, D. (1997). Selenium: an acute-phase reactant? Ann. Clin. Biochem. 34, 437-439.
35. Schneider, M.J., Fiering, S.N., Thai, B., Wu, S.Y., St Germain, E., Parlow, A.F., St Germain, D.L., and Galton, V.A. (2006). Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology 147, 580-589.
36. Schomburg, L. (2007). Selenium in Intensive Care (SIC) study: the XX files are still unresolved. Crit. Care Med. 35, 995-996.
37. Schomburg, L., Schweizer, U., Holtmann, B., Flohé, L., Sendtner, M., and Köhrle, J. (2003). Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem. J. 370, 397-402.
38. Schomburg, L., Schweizer, U., and Köhrle, J. (2004). Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic. Cell. Mol. Life Sci. 61, 1988-1995.
39. Schomburg, L., Riese, C., Michaelis, M., Griebert, E., Klein, M.O., Sapin, R., Schweizer, U., and Köhrle, J. (2005). Synthesis and metabolism of thyroid hormones is preferentially maintained in selenium-deficient transgenic mice. Endocrinology 147, 1306-1313.
40. Schwarz, K. and Foltz, C.M. (1957). Selenium as an integral part of Factor 3 against dietary necrotic liver degeneration. J. Am. Chem. Soc. 79, 3292.
41. Schweizer, U., Schomburg, L., and Savaskan, N.E. (2004). The neurobiology of selenium: lessons from transgenic mice. J. Nutr. 134, 707-710.
42. Schweizer, U., Streckfuss, F., Pelt, P., Carlson, B.A., Hatfield, D.L., Köhrle, J., and Schomburg, L. (2005). Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem. J. 386, 221-226.
43. Stranges, S., Marshall, J.R., Trevisan, M., Natarajan, R., Donahue, R.P., Combs, G.F., Farinaro, E., Clark, L.C., and Reid, M.E. (2006). Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am. J. Epidemiol. 163, 694-699.
44. Suzuki, K.T., Kurasaki, K., Okazaki, N., and Ogra, Y. (2005). Selenosugar and trimethylselenonium among urinary Se metabolites: dose- and age-related changes. Toxicol. Appl. Pharmacol. 206, 1-8.
45. Turner, R.J. and Finch, J.M. (1991). Selenium and the immune response. Proc. Nutr. Soc. 50, 275-285.
46. Villette, S., Kyle, J.A., Brown, K.M., Pickard, K., Milne, J.S., Nicol, F., Arthur, J.R., and Hesketh, J.E. (2002). A novel single nucleotide polymorphism in the 3′ untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol. Dis. 29, 174-178.
47. Waters, D.J., Chiang, E.C., Cooley, D.M., and Morris, J.S. (2004). Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women. Mutat. Res. 551, 91-107.
48. Wingler, K., Bocher, M., Flohé, L., Kollmus, H., and Brigelius-Flohé, R. (1999). mRNA stability and selenocysteine insertion sequence efficiency rank gastrointestinal glutathione peroxidase high in the hierarchy of selenoproteins. Eur. J. Biochem. 259, 149-157.
49. Xia, Y., Hill, K.E., Byrne, D.W., Xu, J., and Burk, R.F. (2005). Effectiveness of selenium supplements in a low-selenium area of China. Am. J. Clin. Nutr. 81, 829-834.